Compagnie Lombard, Odier SCA »

Dyne Therapeutics shares owned by Compagnie Lombard, Odier SCA

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Compagnie Lombard, Odier SCA from 13F filings

Historical chart of Compagnie Lombard, Odier SCA investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Compagnie Lombard, Odier SCA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Compagnie Lombard, Odier SCA

Quarter filed Position value Share count Share price at filing
2024-09-30 $251k 7.0k 35.92
2024-06-30 $247k 7.0k 35.29

More positions owned by Compagnie Lombard, Odier SCA

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Linde SHS (LIN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Palo Alto Networks (PANW)
Procter & Gamble Company (PG)
Merck & Co (MRK)
Home Depot (HD)
Thermo Fisher Scientific (TMO)
General Mills (GIS)
Adobe Systems Incorporated (ADBE)

View all positions for Compagnie Lombard, Odier SCA

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics